glp-1 receptor agonists and cardiovascular outcome trials an update mortality outcomes with vs other glucose-lowering drugs in individuals with NAFLD and type 2 diabetes: a large population-based matched cohort study | Diabetologia Impact of GLP-1 receptor agonists
Description
Obes Surg 27(2):513521 Peng MG, Gokoffski KK (2021) Updates on recent Developments in Idiopathic Intracranial Hypertension
Supplement protocols for GLP-1 users include specific electrolyte recommendations
[4] Ward, Z
Addiction What are the risks of taking compounded GLP-1s
